Search
-
Rare Blood Disorders
Learn about active rare blood disorder and blood cancer clinical trials happening now at Memorial Sloan Kettering, where you may have access to treatments before they’re available elsewhere.
… At Memorial Sloan Kettering, we have significant expertise in caring for people with rare blood disorders. We are committed to improving outcomes for people with these disorders. We believe that research offers the possibility of new treatments. We are focused on developing innovative ideas in our labs
-
Read our screening guidelines for melanoma and discover how 3-D photography is improving our ability to detect this serious disease.
… What is My Risk for Melanoma? A risk factor is anything that increases your chance of getting a disease, such as cancer. Melanoma Risk Factors Learn about the risk factors for melanoma. Melanoma Screening for People With Symptoms or Risk Factors MSK melanoma experts recommend regular screening for people
-
Lea nuestras pautas de detección del melanoma y descubra cómo la fotografía en 3D está mejorando nuestra capacidad para detectar esta grave enfermedad.
… What is My Risk for Melanoma? A risk factor is anything that increases your chance of getting a disease, such as cancer. Melanoma Risk Factors Learn about the risk factors for melanoma. Melanoma Screening for People With Symptoms or Risk Factors MSK melanoma experts recommend regular screening for people
-
The best treatment for your child's germ cell or sex cord stromal tumor depends on a few things, such as the tumor type, grade, and stage.
… The best treatment for your child’s germ cell tumor (GCT) or sex cord stromal tumor depends on a few things. We look at the tumor type and its grade (how the cells appear). We also look at tumor stage. Staging is part of the diagnosis process. It tells you whether a tumor has spread to lymph nodes or
-
Use our online nomogram to calculate the risk of cancer recurrence following surgery for renal cell carcinoma. Results can help physicians and patients make important treatment decisions.
… Our renal cell carcinoma nomogram is an online tool that can be used to predict the likelihood that a patient’s kidney cancer will not recur at five years after surgery, following a new diagnosis. Who Can Use This Tool? This nomogram was designed to be used by physicians and people with renal cell carcinoma
-
People who have received chemotherapy and radiation for other cancers have a slightly increased risk of developing myelodysplastic syndrome (MDS).
… Myelodysplastic syndrome (MDS) has a few known risk factors: People who have already had chemotherapy or radiation treatment for cancer have an increased risk of therapy-related MDS. This is because chemotherapy drugs and radiation therapy can damage the stem cells in the bone marrow. When chemotherapy
-
Glioma
Meet the world-renowned experts who care for people with glioma at Memorial Sloan Kettering.
… Your personal treatment team will include neurologists, brain surgeons, and other experts who’ll use their skills to customize a plan of care that fits your unique needs. They bring expertise, creativity, and passion to every patient. Your team also includes neuropathologists, neuropsychologists, and
-
Ewing Sarcoma
If your child has been diagnosed with Ewing sarcoma, Memorial Sloan Kettering is ready to help. Learn more about Ewing sarcoma and our treatment and approach at Memorial Sloan Kettering Cancer Center.
… What is Ewing sarcoma? Ewing sarcoma is a rare form of cancer that most often affects children and teenagers. It commonly affects bones — such as the ribs, upper arm bone, thighbone, and pelvic bone — but can also affect soft tissues, such as those in the pelvis or chest. Ewing sarcoma can cause pain
-
Melanoma
Learn how our melanoma clinical trials and research might help you or your loved get access to the latest treatments for this serious disease.
… Memorial Sloan Kettering doctors are constantly working to improve treatment for people with melanoma through clinical trials. Participating in a clinical trial may give you access to promising melanoma treatments years before they’re available elsewhere. These studies may offer additional options if
-
… Are you thinking about joining our program? Here’s what you need to know to help you decide. What is the Pancreatic Cancer Screening and Risk Evaluation Program? This program is for people who have a higher risk of getting pancreatic cancer. It is co-led by Dr. Vineet Rolston and Dr. Mengmeng Du . The